Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 7 of 114

  1. 77242113PSO3003

    Janssen-Cilag International N.V.

    Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  2. 77242113PSO3004

    Janssen-Cilag International N.V.

    Moderate to Severe Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  3. 77242113PSO3006

    Janssen-Cilag International N.V.

    Moderate to Severe Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  4. 78278343PCR3001

    Janssen-Cilag International N.V.

    Metastatic Castration-resistant Prostate Cancer (mCRPC)

    phase 3 small molecule active

    1 trial

  5. 78278343PCR3003

    Janssen-Cilag International N.V.

    Metastatic Castration-resistant Prostate Cancer (mCRPC)

    phase 3 small molecule active

    1 trial

  6. 79635322MMY3001

    Janssen-Cilag International N.V.

    Relapsed or Refractory Multiple Myeloma

    phase 3 small molecule active

    1 trial

  7. 8 mg aflibercept (BAY 86-5321) (High Dose)

    Regeneron UK Limited

    Diabetic Macular Edema

    phase 3 small molecule completed

    1 trial

  8. 80202135EBF3001

    Janssen-Cilag International N.V.

    Hemolytic Disease of the Fetus and Newborn (HDFN)

    phase 3 small molecule active

    1 trial

  9. 80202135FNAIT3001

    Janssen-Cilag International N.V.

    Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

    phase 3 small molecule active

    1 trial

  10. 80202135FNAIT3003

    Janssen-Cilag International N.V.

    Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

    phase 3 small molecule active

    1 trial

  11. 80202135SJS3001

    Janssen-Cilag International N.V.

    Sjögren's Disease

    phase 3 small molecule active

    1 trial

  12. 80202135SLE3001

    Janssen-Cilag International N.V.

    Systemic Lupus Erythematosus

    phase 3 small molecule active

    1 trial

  13. 811095

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine Dependence

    phase 3 small molecule completed

    1 trial

  14. 8951-CL-0301

    Astellas Pharma GmbH

    Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

    phase 3 small molecule active

    1 trial

  15. 8951-CL-0302

    Astellas Pharma GmbH

    Claudin (CLDN)18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

    phase 3 small molecule active

    1 trial

  16. 8951-CL-0305

    Astellas Pharma GmbH

    Gastroesophageal Junction Adenocarcinoma, Gastric Cancer, Gastric Adenocarcinoma

    phase 3 small molecule active

    1 trial

  17. 89Zr-CED88004S

    Disc Medicine

    Large B-cell lymphoma

    phase 3 small molecule active

    1 trial

  18. 89Zr-Girentuximab

    Telix Innovations

    Clear Cell Renal Cell Carcinoma

    phase 3 small molecule completed

    2 trials

  19. 89Zr-TLX250 PET/CT

    Telix Innovations

    Clear Cell Renal Cell Carcinoma

    phase 3 small molecule active

    1 trial

  20. 91774

    Bayer HealthCare AG

    Metrorrhagia

    phase 3 small molecule completed

    1 trial

  21. 91781

    Bayer HealthCare AG

    Primary Dysmenorrhea

    phase 3 small molecule completed

    1 trial

  22. 91782

    Bayer HealthCare AG

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  23. 9999

    United Therapeutics Europe Ltd

    Non-Severe Pneumonia

    phase 3 small molecule completed

    1 trial

  24. 9vHPV Vaccine

    Takeda

    Dengue Fever

    phase 3 mab completed

    1 trial

  25. A-101

    Aclaris Therapeutics

    Common Wart

    phase 3 small molecule completed

    2 trials

  26. A-101 Solution

    Aclaris Therapeutics

    Seborrheic Keratosis

    phase 3 small molecule completed

    3 trials

  27. A011-14

    Lacuna Pharma Pty Ltd

    Pulmonary Arterial Hypertension (PAH)

    phase 3 small molecule active

    1 trial

  28. A021502

    The George Institute

    stage III colon adenocarcinoma with deficient MMR

    phase 3 small molecule active

    1 trial

  29. A35-004

    Lacuna Pharma Pty Ltd

    Amyotrophic Lateral Sclerosis (ALS)

    phase 3 small molecule active

    1 trial

  30. A3921145

    Pfizer Australia Pty Ltd

    Juvenile Idiopathic Arthritis (JIA)

    phase 3 small molecule active

    1 trial

  31. A3921210

    Pfizer Australia Pty Ltd

    Ulcerative Colitis (UC)

    phase 3 small molecule active

    1 trial

  32. A4250-015

    Ipsen

    Alagille Syndrome

    phase 3 small molecule active

    1 trial

  33. AB-01-004

    Dr Reddy''s Laboratories (Australia) Pty Ltd

    Rheumatoid Arthritis

    phase 3 small molecule active

    1 trial

  34. AB15003

    AB Science

    Mastocytosis

    phase 3 small molecule active

    1 trial

  35. AB19001

    AB Science

    Amyotrophic Lateral Sclerosis

    phase 3 small molecule active

    1 trial

  36. AB20009

    AB Science

    Multiple Sclerosis

    phase 3 small molecule active

    1 trial

  37. AB23005

    AB Science

    Amyotrophic Lateral Sclerosis

    phase 3 small molecule active

    1 trial

  38. ABC-HCC

    The George Institute

    intermediate-stage hepatocellular carcinoma

    phase 3 small molecule active

    1 trial

  39. ABEMACICLIB , FULVESTRANT

    Eli Lilly Co.

    Breast cancer

    phase 3 small molecule active

    1 trial

  40. ABP 206

    Amgen

    Melanoma

    phase 3 small molecule active

    2 trials

  41. ABX-CT-302EU/EAGLE-i

    Advanced Accelerator Applications

    Prostate Cancer

    phase 3 small molecule active

    1 trial

  42. AC-055-315

    Lacuna Pharma Pty Ltd

    Pulmonary arterial hypertension

    phase 3 small molecule active

    1 trial

  43. AC-203-EBS-007

    Wuhan Createrna Science and Technology Co., Ltd

    Generalized Epidermolysis Bullosa Simplex (EBS)

    phase 3 small molecule active

    1 trial

  44. AC220-168

    Daiichi Sankyo

    Acute myeloid leukemia

    phase 3 small molecule active

    1 trial

  45. ACE-536-LTFU-001

    Celgene Europe Limited

    myelodysplastic syndrome (MDS); beta (β)-thalassemia (THAL); myelofibrosis (MF)

    phase 3 small molecule active

    1 trial

  46. ACE-536-MF-002

    Celgene Europe Limited

    Anemia associated with myeloproliferative neoplasm (MPN)-associated myelofibrosis (MF)

    phase 3 small molecule active

    1 trial

  47. ACE-CL-006

    Lacuna Pharma Pty Ltd

    High Risk Chronic Lymphocytic Leukaemia

    phase 3 small molecule active

    1 trial

  48. ACE-CL-007

    Lacuna Pharma Pty Ltd

    Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.